Development of a DNA vaccine targeting Merkel cell polyomavirus

Vaccine

Volumn 30, Issue 7, 2012, Pages 1322-1329

  Zeng, Qi ^a   Gomez, Bianca P ^b   Viscidi, Raphael P ^b,c   Peng, Shiwen ^b   He, Liangmei ^b   Ma, Barbara ^b   Wu, T C ^b,c   Hung, Chien Fu ^b,c  

^a FUDAN UNIVERSITY   (China)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

DNA vaccine; Merkel cell carcinoma; Merkel cell polyomavirus

Indexed keywords

CANCER VACCINE; DNA VACCINE; DNA VACCINE ENCODING MERKEL CELL POLYOMAVIRUS LT AA1 258; EPITOPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE TARGETING; IMMUNOCOMPETENT CELL; IN VIVO STUDY; MERKEL CELL POLYOMAVIRUS; MERKEL CELL TUMOR; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; ANTIGENS, VIRAL, TUMOR; CD4-POSITIVE T-LYMPHOCYTES; DNA, VIRAL; FEMALE; HUMANS; IMMUNITY, CELLULAR; INJECTIONS, INTRAMUSCULAR; MELANOMA, EXPERIMENTAL; MERKEL CELL POLYOMAVIRUS; MICE; MICE, INBRED C57BL; POLYOMAVIRUS INFECTIONS; VACCINATION; VACCINES, DNA; VIRAL VACCINES;

EID: 84856580245     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.072     Document Type: Article

References (23)

1. Hodgson N.C. Merkel cell carcinoma: changing incidence trends. J Surg Oncol 2005, 89(January (1)):1-4.
2. Mojica P., Smith D., Ellenhorn J.D. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol 2007, 25(March (9)):1043-1047.
3. Allen P.J., Bowne W.B., Jaques D.P., Brennan M.F., Busam K., Coit D.G. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005, 23(April (10)):2300-2309.
4. Feng H., Shuda M., Chang Y., Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319(February (5866)):1096-1100.
5. Shuda M., Feng H., Kwun H.J., Rosen S.T., Gjoerup O., Moore P.S., et al. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci USA 2008, 105(October (42)):16272-16277.
6. Houben R., Shuda M., Weinkam R., Schrama D., Feng H., Chang Y., et al. Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol 2010, 84(July (14)):7064-7072.
7. Hung C.F., Monie A., Alvarez R.D., Wu T.C. DNA vaccines for cervical cancer: from bench to bedside. Exp Mol Med 2007, 39(December (6)):679-689.
8. Tsen S.W., Paik A.H., Hung C.F., Wu T.C. Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells. Expert Rev Vaccines 2007, 6(April (2)):227-239.
9. Lin K., Roosinovich E., Ma B., Hung C.F., Wu T.C. Therapeutic HPV DNA vaccines. Immunol Res 2010, 47(July (1-3)):86-112.
10. Jacob J., Radkevich O., Forni G., Zielinski J., Shim D., Jones R.F., et al. Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice. Cell Immunol 2006, 240(April (2)):96-106.
11. Best S.R., Peng S., Juang C.M., Hung C.F., Hannaman D., Saunders J.R., et al. Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery. Vaccine 2009, 27(September (40)):5450-5459.
12. Kim D., Gambhira R., Karanam B., Monie A., Hung C.F., Roden R., et al. Generation and characterization of a preventive and therapeutic HPV DNA vaccine. Vaccine 2008, 26(January (3)):351-360.
13. Peng S., Ji H., Trimble C., He L., Tsai Y.C., Yeatermeyer J., et al. Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6. J Virol 2004, 78(August (16)):8468-8476.
14. Quezada S.A., Simpson T.R., Peggs K.S., Merghoub T., Vider J., Fan X., et al. Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J Exp Med 2010, 207(March (3)):637-650.
15. Xie Y., Akpinarli A., Maris C., Hipkiss E.L., Lane M., Kwon E.K., et al. Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma. J Exp Med 2010, 207(March (3)):651-667.
16. Cheng W.F., Hung C.F., Chai C.Y., Hsu K.F., He L., Ling M., et al. Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest 2001, 108(September (5)):669-678.
17. Kim T.W., Lee J.H., Hung C.F., Peng S., Roden R., Wang M.C., et al. Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J Virol 2004, 78(May (9)):4638-4645.
18. Kim J.W., Hung C.F., Juang J., He L., Kim T.W., Armstrong D.K., et al. Comparison of HPV DNA vaccines employing intracellular targeting strategies. Gene Ther 2004, 11:1011-1018.
19. Chen C.H., Wang T.L., Hung C.F., Yang Y., Young R.A., Pardoll D.M., et al. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res 2000, 60(February (4)):1035-1042.
20. Trimble C., Lin C.T., Hung C.F., Pai S., Juang J., He L., et al. Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe. Vaccine 2003, 21(September (25-26)):4036-4042.
21. Ji H., Wang T.-L., Chen C.-H., Hung C.-F., Pai S., Lin K.-Y., et al. Targeting HPV-16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine HPV-16 E7-expressing tumors. Hum Gene Ther 1999, 10(17):2727-2740.
22. Hung C.F., Cheng W.F., He L., Ling M., Juang J., Lin C.T., et al. Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes. Cancer Res 2003, 63(May (10)):2393-2398.
23. Hung C.-F., Cheng W.-F., Hsu K.-F., Chai C.-Y., He L., Ling M., et al. Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen. Cancer Res 2001, 61:3698-3703.